Mirae Asset Global Investments Co. Ltd. Sells 54,748 Shares of InterCure Ltd. (NASDAQ:INCR)

Mirae Asset Global Investments Co. Ltd. decreased its position in shares of InterCure Ltd. (NASDAQ:INCRGet Rating) by 6.5% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 782,138 shares of the company’s stock after selling 54,748 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in InterCure were worth $5,523,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Citigroup Inc. increased its holdings in shares of InterCure by 9,567.9% during the first quarter. Citigroup Inc. now owns 5,124 shares of the company’s stock valued at $36,000 after acquiring an additional 5,071 shares in the last quarter. Davy Global Fund Management Ltd bought a new stake in shares of InterCure during the first quarter valued at approximately $152,000. Finally, ETF Managers Group LLC bought a new stake in InterCure during the fourth quarter worth $3,592,000. Institutional investors own 14.99% of the company’s stock.

InterCure Trading Down 0.9 %

Shares of InterCure stock opened at $4.57 on Friday. The stock has a fifty day simple moving average of $5.49 and a 200 day simple moving average of $6.06. InterCure Ltd. has a 12-month low of $4.29 and a 12-month high of $8.77. The company has a market capitalization of $195.30 million and a P/E ratio of 25.39. The company has a current ratio of 1.87, a quick ratio of 1.43 and a debt-to-equity ratio of 0.13.

InterCure Profile

(Get Rating)

InterCure Ltd., together with its subsidiaries, engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Israel and internationally. It offers dried cannabis inflorescences and cannabis extract mixed with oil. The company also invests in biomed sector.

See Also

Want to see what other hedge funds are holding INCR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for InterCure Ltd. (NASDAQ:INCRGet Rating).

Institutional Ownership by Quarter for InterCure (NASDAQ:INCR)

Receive News & Ratings for InterCure Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InterCure and related companies with MarketBeat.com's FREE daily email newsletter.